C

    Curis Inc (CRIS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.49
    +0.00 (+0.00%)

    Market Cap: $3.61M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    51%(20/39)
    Avg Surprise
    -249.50%
    Streak
    1 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-2.01
    Range$-2.29 - $-1.73
    2 analysts
    EPS RevisionsNo revisions (7d)
    1
    1
    30d
    EPS Estimate Drift
    90d ago$-6.73-235.0%
    60d ago$-6.73-235.0%
    30d ago$-6.73-235.0%
    7d ago$-5.06-151.9%
    Current$-2.01
    Revenue Consensus
    $0
    Range$0 - $0
    3 analysts
    Dec 31, 2026
    EPS Consensus$-16.27
    Range$-24.97 - $-8.14
    3 analysts
    Revenue Consensus
    $-2615000
    Range$-2615000 - $-2615000
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-16.27---
    Sep 26EST
    		-$-2.01---
    Jun 26
    		$-4.02$-5.70+29.47%Beat+70.4%
    Mar 26
    		$-25.00$-5.80-331.03%Miss+0.0%
    Dec 25
    		$-9.95$-8.65-15.01%Miss-695.8%
    Sep 25
    		$-9.80$-12.00+18.33%Beat+71.2%
    Jun 25
    		$-13.60N/A+55.12%Beat+66.5%
    Mar 25
    		$-25.00$-25.27+1.07%Beat+39.0%
    Dec 24
    		$-1.25$-0.99-26.26%Miss+96.9%
    Sep 24
    		$-34.00$-38.16+10.90%Beat+20.2%
    Jun 24
    		$-40.60$-36.20-12.15%Miss+15.4%
    Mar 24
    		$-41.00$-42.44+3.39%Beat+14.6%
    Dec 23
    		$-40.60$-43.93+7.58%Beat-33733.3%
    Sep 23
    		$-42.60$-47.15+9.65%Beat+23.9%
    Jun 23
    		$-48.00$-47.00-2.13%Miss+29.4%
    Mar 23
    		$-48.00$-43.00-11.63%Miss+33.3%
    Dec 22
    		$-0.12$-0.13+7.69%Beat+20.0%
    Sep 22
    		$-56.00$-68.00+17.65%Beat-16.7%
    Jun 22
    		$-68.00$-66.00-3.03%Miss-41.7%
    Mar 22
    		$-72.00$-64.00-12.50%Miss-63.6%
    Dec 21
    		$-0.15$-0.13-15.38%Miss-36.4%
    Sep 21
    		$-48.00$-52.00+7.69%Beat-9.1%
    Jun 21
    		$-48.00$-44.00-9.09%Miss+29.4%
    Mar 21
    		$-44.00$-37.00-18.92%Miss-15614.3%
    Dec 20
    		$-0.11$-0.09-22.22%Miss+97.9%
    Sep 20
    		$-44.00$-68.00+35.29%Beat-1057.9%
    Jun 20
    		$-68.00$-80.00+15.00%Beat-1445.5%
    Mar 20
    		$-0.28N/AN/ABeat+95.3%
    Dec 19
    		$-5.20$-0.20-2500.00%Miss+92.8%
    Sep 19
    		$-3.80$-0.20-1800.00%Miss+95.7%
    Jun 19
    		$-4.40$-0.19-2215.79%Miss+95.8%
    Mar 19
    		$-6.00$-0.19-3057.89%Miss+95.7%
    Dec 18
    		$-72.00$-84.00+14.29%Beat-28700.0%
    Sep 18
    		$-88.00$-122.67+28.26%Beat+60.0%
    Jun 18
    		$-104.00$-153.33+32.17%Beat+48.0%
    Mar 18
    		$-140.00$-140.00+0.00%Beat+36.4%
    Dec 17
    		$-0.25$-0.45+44.44%Beat+37.5%
    Sep 17
    		$-220.00$-186.67-17.86%Miss-37.5%
    Jun 17
    		$-200.00$-186.67-7.14%Miss-
    Mar 17
    		$-220.00$-173.33-26.93%Miss-
    Dec 16
    		$-0.40$-0.49+18.37%Beat-
    Sep 16
    		$-160.00$-195.00+17.95%Beat-

    Key Metrics

    Valuation
    P/E Ratio-0.03EV/EBITDA0.56x
    Price/FCF-0.10xFCF Yield-961.10%
    Profitability
    Profit Margin0.00%Operating Margin-833.00%
    ROE-694.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio0.49xQuick Ratio0.49x
    Trading Statistics
    Beta3.09Avg Volume329.54K
    52-Week High$39.0052-Week Low$1.40

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.58
    SMA 20$2.33
    SMA 50$4.35
    SMA 200$13.71
    EMA 10$1.71
    EMA 20$2.35
    EMA 50$4.33
    EMA 200$13.85

    MACD

    Line: -0.93Signal: -1.00Hist: 0.08

    ADX

    ADX: 36.3+DI: 7.0-DI: 16.4

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down92.0
    PSAR$2.22

    Bollinger Bands

    Upper Band$4.69
    Lower Band$-0.03
    %B Position20258%(Upper)
    Band Width0.32

    RSI (14-Day)

    Oversold
    22.8

    Momentum Oscillators

    Stoch %K5.7
    Stoch %D3.9
    Williams %R-91.0
    ROC (10d)-17.2%
    Momentum-0.31
    CCI (20d)-60.3
    MFI (14d)13.5

    Volatility Measures

    ATR (14d)$0.72(48.4%)
    StdDev (20d)1.18
    Hist Vol164.9%(High)

    Volume Flow

    VWAP$1.48
    OBV128.3M
    AD Line44.1B
    CMF (20d)-0.311

    Volume Metrics

    Avg Vol (20d)341.8K
    Vol Ratio0.1x(Low)
    VWMA (20d)$1.93

    Pivot Points

    R3$1.69
    R2$1.64
    R1$1.56
    Pivot Point$1.51
    S1$1.43
    S2$1.38
    S3$1.30

    Advanced Oscillators

    TSI-50.69
    Ultimate Osc39.6
    KST-654.92

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$1.14M$3.18M$2.75M$2.38M$3.35M$2.93M$2.55M$2.09M$2.70M$2.83M
    Cost of Revenue$0$0$36,000$0$0$0$17,000$0$0$0$-24,000$0
    Gross Profit$0$0$1.14M$3.18M$2.75M$2.38M$3.35M$2.93M$2.55M$2.09M$2.72M$2.83M
    Operating Expenses$9.94M$11.52M$-18,481,000$10.10M$11.00M$12.54M$12.34M$13.50M$15.06M$14.55M$14.92M$15.20M
    R&D$6.71M$6.45M$5.83M$6.43M$7.46M$8.54M$8.97M$9.72M$10.25M$9.62M$9.96M$10.38M
    SG&A$3.23M$5.07M$2.88M$3.65M$3.53M$3.98M$3.35M$3.75M$4.79M$4.89M$4.88M$4.76M
    Operating Income$-9,940,000$-11,519,000$19.62M$-6,924,000$-8,251,000$-10,157,000$-8,994,000$-10,567,000$-12,512,000$-12,469,000$-12,199,000$-12,368,000
    Interest Income$62,000$77,000$51,000$80,000$92,000$93,000$227,000$325,000$701,000$515,000$665,000$806,000
    Interest Expense$0$12.68M$263,000$885,000$434,000$552,000$624,000$0$-8,000$0$0$619,000
    Income Before Tax$-8,581,000$-24,199,000$19.36M$-7,729,000$-8,593,000$-10,616,000$-9,618,000$-10,092,000$-11,803,000$-11,876,000$-11,780,000$-12,181,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-8,581,000$-24,199,000$19.36M$-7,729,000$-8,593,000$-10,616,000$-9,618,000$-10,092,000$-11,803,000$-11,876,000$-11,712,000$-12,181,000
    EBITDA$-8,635,000$-24,268,000$19.66M$-6,892,000$-8,209,000$-10,098,000$-8,550,000$-10,350,000$-12,984,000$-12,243,000$-12,150,000$-12,747,000
    EBIT$-8,643,000$-24,276,000$19.62M$-6,924,000$-8,251,000$-10,157,000$-8,994,000$-10,417,000$-12,512,000$-12,391,000$-12,199,000$-12,368,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CRIS

    News

    Curis Inc (CRIS) Technical Analysis: Support, Resistance, Indicators & Moving Averages

    This article provides a technical analysis of Curis Inc (CRIS), detailing its current price momentum, support and resistance levels, and indicator and moving average readings. It notes that CRIS has a momentum score of 7.09 and is suitable for range-bound swing trading, trading between resistance at $4.29 and support at $0.23. The analysis presents a summary of various technical indicators and moving averages, largely suggesting "Sell" or "Neutral" signals, with some indicators showing oversold conditions.

    TradingKey•8/19/26•
    Bearish

    CRIS Reiterated by HC Wainwright & Co. -- Price Target Maintained at $43

    HC Wainwright & Co. has reaffirmed its 'Buy' rating for Curis (CRIS), maintaining a price target of $43.00, despite the company's current unprofitability and moderate GF Score™ of 57/100. Although Curis is considered significantly undervalued by GuruFocus's GF Value™ at $20.18 compared to its current price of $1.82, a cautious approach is advised due to its financial challenges and mixed sentiment from gurus and insiders. The biotech company, focused on oncology therapies, shows promising growth potential but faces profitability issues.

    GuruFocus•8/17/26•
    Bullish

    Curis: Q2 Earnings Snapshot

    Curis Inc. (CRIS) reported a second-quarter loss of $8.6 million, which translates to a loss of $4.02 per share. This information was generated by Automated Insights using data from Zacks Investment Research.

    10TV•8/14/26•
    Bearish

    CURIS INC 10-Q Summary: Revenue $0 Net income ($8.58M), EPS ($4.02) — 10-Q Summary

    CURIS INC (CRIS) reported its Q2 2026 financial results, showing no revenue and a net loss of ($8.58M), an improvement from the prior-year quarter's net loss. The company's clinical focus has shifted to emavusertib combination trials, and regulatory engagement for accelerated approvals is ongoing. Despite a recent offering, liquidity remains constrained, limiting its financial runway into Q4 2026.

    TradingView•8/14/26•
    Bearish

    Curis: Q2 Earnings Snapshot

    Curis Inc. (CRIS) reported a loss of $8.6 million in its second quarter. The Lexington, Massachusetts-based company posted a loss of $4.02 per share. This financial data was generated by Automated Insights using data from Zacks Investment Research.

    Caledonian Record•8/14/26•
    Bearish

    Frequently Asked Questions About CRIS

    Does CRIS pay dividends?
    Curis Inc (CRIS) does not currently pay a regular dividend.
    What is CRIS's market cap?
    Curis Inc (CRIS) has a market capitalization of $3.61M with a current stock price of $1.49.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In